News search results
41 Results for ''
-
Press ReleaseBiomaterial vaccines to make implanted orthopedic devices safer
November 3, 2025 -
CommunityFeyisayo (Sayo) Eweje on Helping Gene Therapies ENTER The Right Cells
May 29, 2025 -
Press ReleaseENTERing a new era of drug delivery
May 15, 2025 -
AwardsKwasi Adu-Berchie named 2024 STAT Wunderkind
October 16, 2024 -
Translation NewsAttivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
October 2, 2024 -
Press ReleaseBoosting CAR-T cell therapies from under the skin
June 12, 2024 -
Press ReleaseExpanding a lymph node, boosting a vaccine
May 6, 2024 -
Press ReleaseDNA origami-based vaccines toward safe and highly-effective precision cancer immunotherapy
March 15, 2024 -
Research SpotlightsChanging the calculus of cancer treatment
January 25, 2024 -
Press ReleaseBiomaterial-delivered one-two punch boosts cancer immunotherapy
July 13, 2023 -
Research SpotlightsImmunotherapy’s Next Act
March 15, 2023 -
Translation NewsWyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences
December 19, 2022 -
CommunityYang (Claire) Zeng on Developing DoriVac, the Next Generation of Vaccine Delivery Technology
September 28, 2022 -
Translation NewsThe Wyss Institute’s 2022-2023 Validation Projects
September 12, 2022 -
Research SpotlightsActivating STING could make brain tumors more susceptible to treatment
July 14, 2022 -
Research SpotlightsNew cancer vaccine delivers double punch to tumors
May 27, 2022 -
CommunityGirija Goyal on Increasing the Efficacy of Clinical Trials
March 4, 2022 -
Press ReleasePredicting influenza virus evolution in a human Lung Airway Chip
September 20, 2021 -
Press ReleaseBiomaterial vaccines ward off broad range of bacterial infections and septic shock
July 8, 2021 -
AwardsHarvard “Immuno-engineering to Improve Immunotherapy” (i3) Center at the Wyss Institute awards first grant to Dana-Farber cancer immunologist Eric Smith
January 21, 2021 -
Press ReleaseA viable vaccine for tough tumors
November 10, 2020 -
CommunityThe OMNIVAX team sets out to follow their dream
October 22, 2020 -
Research SpotlightsPutting a crown on OMNIVAX
August 17, 2020 -
Press ReleaseBetter vaccines are in our blood
July 13, 2020 -
Press ReleaseDirect control of dendritic cells for tracking and immune modulation
May 18, 2020 -
Press ReleaseSoup to Nuts
April 24, 2020 -
Research Spotlights“The world changed, so we changed with it”
April 7, 2020 -
Press ReleaseA solid vaccine for liquid tumors
January 14, 2020 -
Press ReleaseAnother trick up the immune system’s sleeve: regrowing blood vessels
July 31, 2019 -
Research SpotlightsHarnessing Nature to Beat Cancer
February 28, 2019 -
AwardsWyss Researcher Named 2017 STAT Wunderkind
October 13, 2017 -
Video/AnimationIntroducing ‘Immuno-Materials’ to immunotherapy
June 28, 2017 -
CommunitySeeing Is Believing: Therapeutic Cancer Vaccines
April 5, 2017 -
Press ReleaseWyss Institute’s human gut-on-a-chip goes viral
February 1, 2017 -
Press ReleaseMaking every cell matter
October 31, 2016 -
Press ReleaseJust add water: Biomolecular manufacturing ‘on-the-go’
September 22, 2016 -
Press ReleaseHarvard’s Wyss Institute to lead multi-institutional project to uncover underlying causes of tolerance to infection
May 31, 2016 -
Press ReleaseMicrobiomes could hold keys to improving life as we know it
October 29, 2015 -
Press ReleaseInciting an immune attack on cancer cells
August 25, 2015 -
Press ReleaseDavid Mooney receives grant to develop animal contraceptive vaccine
January 13, 2015 -
Press ReleaseInjectable 3D vaccines could fight cancer and infectious diseases
December 8, 2014